Clinical Trials Directory

Trials / Completed

CompletedNCT00908999

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

FMRI of Anosognosia in Amnestic MCI and AD: Focus on Cortical Midline Structures

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Accepted

Summary

This is a three year fMRI study conducted at the University of Wisconsin (UW) Hospital and the William. S. Middleton VA Hospital. This study is guided by the hypothesis that reduced fMRI activity and connectivity cortical midline structures (i.e., medial frontal and ventral posterior cingulate cortex) are physiologic abnormalities that relate strongly to the compromised insight into cognitive deficits, or anosognosia, shown by a subset of individuals with amnestic MCI (aMCI) and AD. Further, the investigators hypothesize that these regional changes in fMRI activity are predictive of faster progression from aMCI to AD.

Conditions

Timeline

Start date
2008-04-01
Primary completion
2011-09-01
Completion
2011-09-01
First posted
2009-05-27
Last updated
2011-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00908999. Inclusion in this directory is not an endorsement.